Provention bio appoints jan hillson, m.d., as senior vice president of clinical development

Red bank, n.j., nov. 17, 2021 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced the appointment of jan hillson, m.d.

PRVB Ratings Summary

PRVB Quant Ranking